The Office of Cancer Clinical Proteomics Research (OCCPR) promotes the sharing and dissemination of laboratory tested technologies and reagents to benefit and promote research across the world. To this regard, several key resources (i.e. data, software tools, reagents, biospecimens and documents) have been developed in OCCPR's initiatives have been made publicly available :
In addition to these resources and tools, the Antibody Portal houses over 190 monoclonal antibodies developed against 69 different antigens. Each of these antibodies is publicly available via dual distribution mechanisms (academia/industry), all of which have been well-characterized with standard operating procedures and data related to each characterization procedure.